TVTX Stock Analysis: Buy, Sell, or Hold?
TVTX - Travere Therapeutics, Inc. Common Stock
$27.55
0.30 (1.08%)
▲
5d:
-0.74%
30d:
-7.54%
90d:
-30.51%
BUY
HIGH Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: May 07, 2026
Smart Money Accumulation
TVTX is down 3.5% this week, but smart money is accumulating calls. Top strike: $15 2026-06-18 with 6 OI. Call ratio: 100% View Scanner →
Strength: 6.7/10
Get Alerted When TVTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: TVTX trading at deep discount. Market pricing in -23.5% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: TVTX trading at deep discount. Market pricing in -23.5% annual earnings decline, creating value opportunity for patient investors.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$118.67
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$73.68
62.6% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 14.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: TVTX is currently trading at $27.55, which is considered slightly low relative to its 30-day fair value range of $27.30 to $29.60. From a valuation perspective, the stock is trading at a discount (Forward PE: 6.4) compared to its historical average (14.3). Remarkably, the market is currently pricing in an annual earnings decline of 23.5% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, TVTX is in a strong uptrend. Immediate support is located at $26.15, while resistance sits at $28.62.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $42.50 (+56.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, TVTX is in a strong uptrend. Immediate support is located at $26.15, while resistance sits at $28.62.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $42.50 (+56.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$27.30 -
$29.60
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 56.0% below Wall St target ($42.50)
Fair Price Analysis
30-Day Fair Range
$27.30 -
$29.60
Current vs Fair Value
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$26.15
Resistance Level
$28.62
Current Trend
Strong Uptrend
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
6.39
Wall Street Target
$42.50
(+56.0%)
Revenue Growth (YoY)
73.4%
Profit Margin
-5.2%
Valuation Discount vs History
-23.5% cheaper
PE vs Historical
6.4 vs 14.3
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-23.5%
(market-implied from PE analysis)
1-Year Target
$24.53
(-10%)
2-Year Target
$22.07
(-19%)
3-Year Target
$19.87
(-27%)
3-Yr Target (if PE normalizes)
(PE: 6→14)
$44.42
(+63%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.4, Growth: 168.5%)
$322.16
(+1082%)
Base:
(SPY PE: 6.4, Growth: 168.5%)
$91.97
(+238%)
Bear:
(PE: 5.4, Growth: 168.5%)
$78.17
(+187%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 6.4 to 14.3
Stabilization Target:
$60.94
(+123.6%)
PE Expansion Potential:
+123.6%
Share & Embed Analysis
Last updated: March 30, 2026 3:22 PM ET
Data refreshes hourly during market hours. Next update: 4:22 PM
Data refreshes hourly during market hours. Next update: 4:22 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TVTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
20
Sells
Net
INSIDERS SELLING
Recent Transactions
Elizabeth E Reed
SELL
10000 shares
2026-03-16
Christopher R Cline
SELL
1745 shares
2026-02-04
Jula Inrig
SELL
1779 shares
2026-02-04
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$449 | 56 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$79 | 63 BUY |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$33 | 45 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$101 | 60 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$26 | 54 HOLD |
Advanced TVTX Option Strategies
Professional options setups generated by AI based on today's TVTX price and gamma walls.
